The importance of including confounders when building artificial intelligence-based support tools to quantify oocyte viability. By Dr. Cristina Hickman, Chief Clinical Officer, Fairtility

Yael Fruchter-Goldmeier, Ben Kantor, Assaf Ben-Meir, Tamar Wainstock, Itay Erlich, Eliahu Levitas, Yoel Shufaro, Onit Sapir & Iris Har-Vardi